Lack of Human PK/PD : There are no published human clinical trials defining the optimal therapeutic dose (TD) or minimal effective dose (MED) for either peptide in humans [2]
NNMT in Cardiovascular Disease 5-Amino-1MQ as a Research Tool (MDPI, 2025) NNMT Inhibition as a Strategy for Cardiovascular Metabolic Pathway Research A 2025 review published in Biomolecules (MDPI) examined NNMT as a metabolic regulator in cardiovascular disease pathogenesis and identified 5-Amino-1MQ as a key research tool for investigating NNMT-mediated cardiovascular metabolic pathways
Useful experimental controls may include vehicle-treated controls, positive controls for migration or angiogenesis, pathway inhibitors for NO or FAK-related signaling, and analytical confirmation of peptide identity and purity
We often combine 23 peptides in a synergistic TMJ protocol alongside our established functional treatment approaches
Blood tests, like serum B12 levels and complete blood counts, are key to making these decisions
Fatigue and energy fluctuations Fatigue is a frequently reported side effect, particularly in the first few weeks of treatment and after dose escalations
